UnitedHealth Group Incorporated $UNH Shares Sold by Beacon Pointe Advisors LLC

Beacon Pointe Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 60,431 shares of the healthcare conglomerate’s stock after selling 215 shares during the quarter. Beacon Pointe Advisors LLC’s holdings in UnitedHealth Group were worth $18,853,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of UNH. Hemington Wealth Management increased its holdings in UnitedHealth Group by 2.5% in the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after purchasing an additional 28 shares in the last quarter. Tlwm grew its stake in shares of UnitedHealth Group by 1.0% in the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after buying an additional 28 shares in the last quarter. Endowment Wealth Management Inc. lifted its position in UnitedHealth Group by 5.0% during the 1st quarter. Endowment Wealth Management Inc. now owns 650 shares of the healthcare conglomerate’s stock worth $341,000 after acquiring an additional 31 shares in the last quarter. Alesco Advisors LLC grew its position in UnitedHealth Group by 6.2% in the first quarter. Alesco Advisors LLC now owns 562 shares of the healthcare conglomerate’s stock valued at $294,000 after acquiring an additional 33 shares in the last quarter. Finally, Forefront Analytics LLC lifted its position in shares of UnitedHealth Group by 4.2% during the first quarter. Forefront Analytics LLC now owns 820 shares of the healthcare conglomerate’s stock worth $430,000 after purchasing an additional 33 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 1.9%

UnitedHealth Group stock opened at $323.36 on Tuesday. The company has a 50-day simple moving average of $343.00 and a 200-day simple moving average of $315.29. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The firm has a market capitalization of $292.91 billion, a P/E ratio of 16.88, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $622.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.15 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. KeyCorp boosted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. UBS Group boosted their price target on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Bank of America lifted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. TD Cowen raised their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.